CLINICAL TRIALS PROFILE FOR DESOXIMETASONE
✉ Email this page to a colleague
All Clinical Trials for DESOXIMETASONE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01018134 ↗ | Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study | Completed | Taro Pharmaceuticals USA | Phase 2 | 2009-11-01 | The objectives of this study are to evaluate the efficacy and safety of two dosing regimens of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients with moderate to severe plaque psoriasis. |
| NCT01043393 ↗ | Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study | Completed | Taro Pharmaceuticals USA | Phase 2 | 2010-02-01 | The objective of this study is to evaluate the potential of desoximetasone 0.25% topical spray to suppress HPA axis function. The potential for adrenal suppression will be assessed following multiple dosing with Desoximetasone 0.25% Topical Spray in patients with moderate to severe plaque psoriasis. The secondary objectives are to evaluate the efficacy parameters and to evaluate the adverse event (AE) profile. |
| NCT01206387 ↗ | Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis | Completed | Taro Pharmaceuticals USA | Phase 3 | 2010-08-01 | efficacy study in patients with moderate to severe plaque psoriasis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DESOXIMETASONE
Condition Name
Clinical Trial Locations for DESOXIMETASONE
Trials by Country
Clinical Trial Progress for DESOXIMETASONE
Clinical Trial Phase
Clinical Trial Sponsors for DESOXIMETASONE
Sponsor Name
